Trials involving intravenous infusion of autologous MSCs showed a trend towards motor function improvements and reduced lesion volumes. 60 There was an open-label, observer-blinded trial involving 85 patients with severe middle cerebral artery infarcts.
← all excerpts
Revolutionizing Stroke Recovery: Unveiling the Promise of Stem Cell Therapy.
1
—
—